X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868696/0/en/Gain-Therapeutics-Announces-Positive-Results-from-the-Single-Ascending-Dose-SAD-Part-of-the-Phase-1-Clinical-Trial-of-GT-02287-a-Novel-GCase-Targeting-Small-Molecule-Therapy-for-GB.html
https://www.globenewswire.com/news-release/2024/04/08/2859262/0/en/Gain-Therapeutics-Bolsters-Management-Team-with-the-Appointment-of-Gene-Mack-as-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/04/01/2855237/0/en/Gain-Therapeutics-Strengthens-Management-Team-and-Appoints-Jonas-Hannestad-M-D-Ph-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2024/03/26/2852284/0/en/Gain-Therapeutics-Reports-Financial-Results-for-Year-End-2023-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/15/2847256/0/en/Gain-Therapeutics-to-Present-at-Public-Ventures-Discovery-Day.html
https://www.globenewswire.com//news-release/2024/03/05/2840374/0/en/Gain-Therapeutics-Presents-Data-at-the-AD-PD-2024-Conference-Demonstrating-the-Mechanism-of-Action-of-GT-02287-its-Clinical-Stage-GCase-Regulator-for-the-Treatment-of-Parkinson-s-D.html
https://www.globenewswire.com//news-release/2024/02/27/2836361/0/en/Gain-Therapeutics-Announces-the-Initiation-of-the-Multiple-Ascending-Dose-MAD-Part-of-the-Phase-1-Clinical-Trial-of-GT-02287-a-Novel-GCase-targeting-Small-Molecule-Therapy-for-GBA1.html
https://www.globenewswire.com//news-release/2024/02/14/2829349/0/en/Gain-Therapeutics-Announces-2024-R-D-Update-on-Parkinson-s-Disease-with-KOL-Analyst-Insight.html
https://www.fiercebiotech.com/research/gain-therapeutics-clinical-parkinsons-drug-restores-motor-function-mice
https://www.globenewswire.com//news-release/2024/02/06/2824252/0/en/Gain-Therapeutics-GT-02287-Completely-Restores-Motor-Function-in-Mouse-Models-of-Parkinson-s-Disease.html
Market Place
Share 
